UNSPSC 51273908: Benzethonium chloride/benzocaine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE700. This VA Drug Class (DE700) classifies this compound as belonging to the group LOCAL ANESTHETICS, TOPICAL.

UNSPSC 51273908 Benzethonium chloride/benzocaine is a Commodity code, but the recent state and local opportunities tagged under it do not align with the code's nominal scope. The three most recent opportunities solicited under this code involve naloxone and drug deactivation systems, a therapeutic pharmacy initiative focused on direct-to-manufacturer prescription fulfillment, and generic multi-source pharmaceuticals and over-the-counter products — none of which are benzethonium chloride or benzocaine products. The mismatch suggests either misclassification in the state and local procurement systems or that the code is being used as a catch-all for pharmaceutical procurement more broadly. Based on the posted opportunities, state and local buyers using this code are primarily seeking pharmaceutical products, systems for opioid response and harm reduction, and prescription fulfillment infrastructure rather than specific topical anesthetics or antiseptic compounds.

The issuing bodies span county health departments, state health and human services agencies, and multi-state cooperative purchasing alliances. Seminole County, Florida issued an IFB (Solicitation Number IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013, posted April 3, 2026) to explore direct-to-manufacturer prescription programs and vendor capabilities for self-insured pharmacy benefit management. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (Solicitation Number S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to serve participating state and local government facilities including Oregon, with products available by May 15, 2026 and contract effectiveness July 1, 2026. Recent activity shows scattered geographic spread across Florida, Texas, and the Upper Midwest, but the mismatch between the code's nominal pharmaceutical chemical compound and the actual solicitation scope indicates limited relevance for vendors supplying benzethonium chloride or benzocaine specifically.